{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:28:19Z","timestamp":1790814499205,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jgar.2024.09.002","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:19:26Z","timestamp":1726762766000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Age and gender in drug resistance tuberculosis: A cross-sectional case study at a national tuberculosis reference hospital in Nigeria"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-9205","authenticated-orcid":false,"given":"Suzie","family":"Madaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawal Dahiru","family":"Rogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazeed Garba","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2024.09.002_bib0001","unstructured":"World Health Organization. Global tuberculosis report 2022. World Health Organization; 2021. https:\/\/iris.who.int\/bitstream\/handle\/10665\/363752\/9789240061729-eng.pdf. Accessed 12th September 2023."},{"key":"10.1016\/j.jgar.2024.09.002_bib0002","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijid.2022.03.026","article-title":"Drug resistant TB \u2013 latest developments in epidemiology, diagnostics and management","volume":"124","author":"Tiberi","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2024.09.002_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.612675","article-title":"Evolution of drug-resistant Mycobacterium tuberculosis strains and their adaptation to the human lung environment","volume":"12","author":"Allu\u00e9-Guardia","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2024.09.002_bib0004","unstructured":"Centers for Disease Control and Prevention 2022. Drug-resistant TB, https:\/\/www.cdc.gov\/tb\/topic\/drtb\/default.htm; 2022 [accessed 10.04.2023]."},{"key":"10.1016\/j.jgar.2024.09.002_bib0005","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.934292","article-title":"updates from the World Health Organization (WHO) on global treatment recommendations for drug-susceptible and multidrug-resistant tuberculosis","volume":"27","author":"Parums","year":"2021","journal-title":"Med Sci Monitor"},{"key":"10.1016\/j.jgar.2024.09.002_bib0006","unstructured":"World Health Organization. WHO operational handbook on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment. World Health Organization; 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240006997. Accessed 4th October 2023."},{"key":"10.1016\/j.jgar.2024.09.002_bib0007","series-title":"Global tuberculosis report 2021","year":"2020"},{"key":"10.1016\/j.jgar.2024.09.002_bib0008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1590\/0074-02760150306","article-title":"A molecular platform for the diagnosis of multidrug-resistant and pre-extensively drug-resistant tuberculosis based on single nucleotide polymorphism mutations present in Colombian isolates of Mycobacterium tuberculosis","volume":"111","author":"Mart\u00ednez","year":"2016","journal-title":"Mem Instit Oswaldo Cruz"},{"issue":"4","key":"10.1016\/j.jgar.2024.09.002_bib0009","first-page":"400","article-title":"Identification of serum cytokine biomarkers associated with multidrug resistant tuberculosis (MDR-TB)","volume":"1","author":"Mensah","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.jgar.2024.09.002_bib0010","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/S095026882100279X","article-title":"Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance","volume":"150","author":"Wang","year":"2022","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jgar.2024.09.002_bib0011","series-title":"WHO global lists of high burden countries for tuberculosis (TB), TB\/HIV and multidrug\/rifampicin-resistant TB (MDR\/RR-TB), 2021\u20132025","year":"2021"},{"key":"10.1016\/j.jgar.2024.09.002_bib0012","unstructured":"FRoN. First national TB prevalence survey 2012, Nigeria, http:\/\/ntblcp.gov.ng; 2012. Accessed 16th October 2023."},{"key":"10.1016\/j.jgar.2024.09.002_bib0013","unstructured":"World Health Organization. First National TB Prevalence Survey, Nigeria; 2012. https:\/\/www.health.gov.ng\/doc\/First%20National%20TB%20Prevalence%20Survey%20Report.pdf. Accessed 8th December 2021."},{"key":"10.1016\/j.jgar.2024.09.002_bib0014","unstructured":"Global Tuberculosis Report 2020 Geneva: World Health Organization; 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240013131. Accesssed 8th December 2021."},{"key":"10.1016\/j.jgar.2024.09.002_bib0015","unstructured":"USAID (2022). Nigeria Tuberculosis Roadmap Overview, Fiscal Year 2022. Nigeria Tuberculosis Roadmap Overview, Fiscal Year 2021, usaid.gov. https:\/\/www.usaid.gov\/sites\/default\/files\/2022-05\/Nigeria_TBRM21_TB_DIAH_Version_Final.pdf. Accessed 5th December 2021."},{"key":"10.1016\/j.jgar.2024.09.002_bib0016","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ijid.2021.02.091","article-title":"Zoonotic tuberculosis \u2013 the changing landscape","volume":"113","author":"Kock","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2024.09.002_bib0017","series-title":"Tuberculosis in cattle and humans in Plateau state, Nigeria. Doctoral dissertation","author":"Fiore","year":"2023"},{"key":"10.1016\/j.jgar.2024.09.002_bib0018","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00284-022-03046-6","article-title":"Prevalence and retrospective insight on tuberculosis in human patients in Cross River State, Nigeria; one health approach to its control","volume":"79","author":"Bikom","year":"2022","journal-title":"Curr Microbiol"},{"issue":"1","key":"10.1016\/j.jgar.2024.09.002_bib0019","doi-asserted-by":"crossref","DOI":"10.15212\/ZOONOSES-2021-0021","article-title":"Global control of tuberculosis: current status and future prospects","volume":"2","author":"Huang","year":"2022","journal-title":"Zoonoses"},{"issue":"9","key":"10.1016\/j.jgar.2024.09.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010729","article-title":"Ghali-Mohammed I. One Health risk challenges and preparedness regarding bovine tuberculosis at abattoirs in North-central Nigeria: associated drivers and health belief","volume":"16","author":"Odetokun","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2024.09.002_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1204525","article-title":"ETHICOBOTS Consortium. Zoonotic tuberculosis in a high bovine tuberculosis burden area of Ethiopia","author":"Ayalew","year":"2023","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.jgar.2024.09.002_bib0022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5588\/ijtld.22.0393","article-title":"One Health\u2019 approach to end zoonotic TB","volume":"27","author":"Villa","year":"2023","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jgar.2024.09.002_bib0023","series-title":"The immunological basis for immunization series. Module 5: tuberculosis","author":"Derobert","year":"2021"},{"key":"10.1016\/j.jgar.2024.09.002_bib0024","first-page":"2","article-title":"The immunological basis for immunization series","volume":"3","author":"Borrow","year":"2006","journal-title":"Module"},{"issue":"1","key":"10.1016\/j.jgar.2024.09.002_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5588\/ijtld.21.0488","article-title":"Opportunities to prevent and manage undernutrition to amplify efforts to end TB","volume":"26","author":"Darnton-Hill","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.jgar.2024.09.002_bib0026","first-page":"250","article-title":"Rifampicin resistant tuberculosis among patients attending General Hospital, Kagarko, Kaduna State, Nigeria","volume":"21","author":"Bitet","year":"2020","journal-title":"Afr J Clin Exp Microbiol"},{"issue":"3\u20136","key":"10.1016\/j.jgar.2024.09.002_bib0027","first-page":"38","article-title":"Prevalence and associated risk factors of drug resistant tuberculosis in a tertiary hospital, Kaduna Northwest Nigeria \u2013 a 5-year review","volume":"28","author":"Ogunsina","year":"2021","journal-title":"Niger Hosp Pract"},{"issue":"2","key":"10.1016\/j.jgar.2024.09.002_bib0028","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/tropicalmed8020104","article-title":"Gender and drug-resistant tuberculosis in Nigeria","volume":"8","author":"Oladimeji","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.jgar.2024.09.002_bib0029","article-title":"Emerging threat of drug-resistant tuberculosis and trends in the era of COVID-19: a descriptive study from northwestern Nigeria","volume":"28","author":"Dayyab","year":"2022","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"1","key":"10.1016\/j.jgar.2024.09.002_bib0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4314\/jcmphc.v35i1.10","article-title":"Comparative study of patients' adherence between hospital-based and community based treatment for multidrug resistant tuberculosis (MDR-TB) in Kaduna State","volume":"35","author":"Adagba","year":"2023","journal-title":"J Comm Med Prim Health Care"},{"issue":"3","key":"10.1016\/j.jgar.2024.09.002_bib0031","doi-asserted-by":"crossref","first-page":"116","DOI":"10.46903\/gjms\/18.03.897","article-title":"Distribution of DR-TB by sex, age groups, occupation, province, division, district, type of disease, type of drug resistance, treatment regimen and outcome of treatment in DR-TB population in DI Khan Division, Pakistan","volume":"18","author":"Saleem","year":"2020","journal-title":"Gomal J Med Sci"},{"key":"10.1016\/j.jgar.2024.09.002_bib0032","first-page":"1","article-title":"Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB\/RIF","author":"Seifert","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jgar.2024.09.002_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05157-6","article-title":"Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jgar.2024.09.002_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-023-01107-x","article-title":"Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Salari","year":"2023","journal-title":"Infect Dis Poverty"},{"issue":"3","key":"10.1016\/j.jgar.2024.09.002_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pulmoe.2018.03.004","article-title":"Tuberculosis and gender \u2013 factors influencing the risk of tuberculosis among men and women by age group","volume":"24","author":"Mar\u00e7\u00f4a","year":"2018","journal-title":"Pulmonology"},{"key":"10.1016\/j.jgar.2024.09.002_bib0036","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00127-013-0672-4","article-title":"Prevalence of psychological symptoms in contemporary Chinese rural-to-urban migrant workers: an exploratory meta-analysis of observational studies using the SCL-90-R","volume":"48","author":"Zhong","year":"2013","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"2","key":"10.1016\/j.jgar.2024.09.002_bib0037","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/jomt.jomt_25_17","article-title":"Tuberculosis and the determinants of treatment outcome in Zaria, North Western Nigeria \u2013 a nine-year (2007\u20132015) epidemiological review","volume":"19","author":"Oyefabi","year":"2017","journal-title":"J Med Trop"},{"key":"10.1016\/j.jgar.2024.09.002_bib0038","article-title":"Outcome of community-initiated treatment of drug-resistant tuberculosis patients in Akwa Ibom State, Nigeria","author":"Asuquo","year":"2022","journal-title":"Texila International Journal of Academic Research"},{"issue":"4","key":"10.1016\/j.jgar.2024.09.002_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215542","article-title":"Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria \u2013 a retrospective cohort study","volume":"14","author":"Oga-Omenka","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jgar.2024.09.002_bib0040","unstructured":"Oga-Omenka C. Timely treatment initiation of free drug-resistant tuberculosis care in Nigeria?: a mixed methods study of patient experience, socio-demographic characteristics and health system factors.papyrus.bib.umontreal.ca. 2021. Thesis 16032021."},{"key":"10.1016\/j.jgar.2024.09.002_bib0041","doi-asserted-by":"crossref","first-page":"98","DOI":"10.51505\/ijmshr.2022.6408","article-title":"Barriers to uptake of drug resistant tuberculosis (DRTB) services and Care in Nigeria: lessons learnt from implementation of community management of DR TB patients","volume":"6","author":"Chidinma","year":"2022","journal-title":"International Journal of Medical Science and Health Research"},{"issue":"3","key":"10.1016\/j.jgar.2024.09.002_bib0042","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5897\/JPHE2023.1448","article-title":"Drug resistant tuberculosis treatment service alignment with health seeking behaviour in selected states in Nigeria","volume":"15","author":"Odume","year":"2023","journal-title":"Journal of Public Health and Epidemiology"},{"issue":"1","key":"10.1016\/j.jgar.2024.09.002_bib0043","first-page":"1","article-title":"Predictors of survival among patients under multi-drug resistant tuberculosis treatment in Ogun State Treatment Center, Nigeria","volume":"6","author":"Olarewaju","year":"2023","journal-title":"Journal of Epidemiological Society of Nigeria"},{"issue":"3","key":"10.1016\/j.jgar.2024.09.002_bib0044","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/microbiolres13030043","article-title":"Patterns of presentation of drug-resistant tuberculosis in Nigeria: a retrospective file review","volume":"13","author":"Oladimeji","year":"2022","journal-title":"Microbiol Res (Pavia)"},{"issue":"2","key":"10.1016\/j.jgar.2024.09.002_bib0045","first-page":"641","article-title":"Prevalence of tuberculosis, rifampicin resistant tuberculosis and associated risk factors in presumptive tuberculosis patients attending some hospitals in Kaduna, Nigeria","volume":"23","author":"Olatunji","year":"2023","journal-title":"The Nigerian Health Journal"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652400170X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652400170X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T13:25:35Z","timestamp":1734701135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371652400170X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"alternative-id":["S221371652400170X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2024.09.002","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age and gender in drug resistance tuberculosis: A cross-sectional case study at a national tuberculosis reference hospital in Nigeria","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2024.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}